Pfizer, BioNTech wants EU OK to use COVID-19 vaccine in children



London — Pfizer and BioNTech have requested European drug regulators to approve the expansion of the coronavirus vaccine to children aged 12 to 15 years. Access to the first shot.

In a statement on Friday, the two pharmaceutical companies said their submission to the European Medicines Agency was based on an advanced study of more than 2,000 adolescents who showed that the vaccine was safe and effective. Said. Children will continue to be monitored for long-term protection and safety for an additional two years. BioNTech and Pfizer had previously requested that an emergency use authorization with the US Food and Drug Administration be extended to children aged 12 to 15 years.

Germany’s Health Minister Jens Spahn welcomed the news that the vaccine may soon give older children a green light.

“With approval, this could make an even bigger difference in our vaccine campaign,” he told bystanders of a visit to a vaccine manufacturing plant in the town of Reinbek, Germany.

Most COVID-19 vaccines deployed worldwide are for adults at high risk for coronavirus.

Approximately 13% of COVID-19 cases recorded in the United States are children. Children are much less likely to get a more serious illness than adults, according to the American Academy of Pediatrics, but at least 268 people have died of COVID-19 and more than 13,500 are hospitalized in the United States alone. It’s more than dying from the flu in the average year. Few people have developed a serious inflammatory condition associated with the coronavirus.

Immunizing children against COVID-19 also made it more difficult for authorities to reopen school as it was sometimes difficult to force children to adhere to physical distance and wearing masks. It may give you confidence.

Other COVID-19 vaccine makers, including AstraZeneca, Moderna, Johnson & Johnson, are also studying whether their shots can be safely used in children.

The COVID-19 vaccine, manufactured by Pfizer and BioNTech, was the first vaccine approved by the EMA last December and was approved by anyone over the age of 16 across the EU block in 27 countries.

Frank Jordan

Posted on